You May be Entitled to Significant Compensation Talc breast cancer. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

J&J’s proposed talc settlement will be worth 400 million dollars to US state AGs. Talc Breast Cancer .

Johnson & Johnson (JNJ.N) has put the amount of $400 million for resolving U.S. state consumer protection actions as part of its larger $8.9 billion effort to settle allegations that its Baby Powder and other talc-based ingredients cause cancer. Talc breast cancer.

J&J subsidiary LTL Management filed a bankruptcy plan in New Jersey late on Monday that describes how the company intends to pay different types of cancer victims as part of an arrangement for bankruptcy. Talc breast cancer. J&J has claimed that its Talc products are safe, and don’t cause cancer. It is attempting for the second time to end more than 38,000 cases in bankruptcy, and to prevent any new cases from arising in the future.
LTL’s bankruptcy plan would pay $400 million into a separate trust for claims brought in state courts by attorneys general alleging that J&J was in violation of state unfair business practices and consumer protection laws by misleading consumers about the dangers of its talc products.

A number of states had already initiated consumer protection measures against J&J prior to the time that LTL’s bankruptcy filing stopped those investigations from proceeding in 2021. Talc breast cancer. New Mexico and Mississippi had already initiated suit for damages against Johnson & Johnson before then as well as the states of Arizona, Maryland, North Carolina, Texas and Washington had issued subpoenas or civil investigative demands in LTL’s court papers.

New Mexico and Mississippi have taken steps to halt the bankruptcy of LTL in a joint move with cancer victims as well as their counterparts from the U.S. Justice Department’s bankruptcy watchdog, who argue that a profit-making firm like J&J does not qualify for bankruptcy protections designed for those struggling with debt.
The company’s initial attempt to resolve the lawsuits in bankruptcy was thrown out after similar arguments. A U.S. appellate court ruled in favor of LTL wasn’t in “financial trouble” and was not eligible to receive bankruptcy relief. Talc breast cancer. LTL filed a second bankruptcy less than two hours after the decision to dismiss, arguing that the second bankruptcy was different as there was less money available and more support for the settlement.

New Mexico and Mississippi said in their motion to dismiss LTL’s renewed bankruptcy violates the law enforcement powers of the state by seeking to unilaterally limit the liability of the company in state consumer protection laws.

Talc Breast Cancer

LTL’s new filings also included more information about how the company plans to evaluate and pay for cancer claims in the event that the bankruptcy plan is approved.

The maximum amount under the settlement will be $500,000 for people diagnosed with terminal mesothelioma before the age of 45, and $260,000 for people diagnosed with advanced ovarian cancer prior to age 45.

The proposed settlement offers discounts based on the severity and type of the cancer, the person’s age, previous usage of talc and other variables. Talc breast cancer. For example, a woman who used the talc product on a regular basis, had the family history of ovarian cancer and was diagnosed Stage II cancer of the ovary when she was 55 could be in line for a $21,125 payment under the program.

Judge ordains J&J, talc opponents to engage in settlement talks.

After another round of hearings in Johnson &Johnson’s attempt to employ a Texas Two Step bankruptcy strategy to settle talc lawsuits and federal bankruptcy judge Michael Kaplan has ordered the firm and the people who opposed the plan to enter into settlement talks, Bloomberg reports.

In its second bankruptcy effort for LTL management, a subsidiary founded by J&J to manage the claims company proposed a settlement of $8.9 billion. Talc breast cancer. While a group of law firms representing plaintiffs is in favor of the offer, another group is against the settlement.

In the last week, an opposition group, called”The Official Committee of Talc Claimants and urging the bankruptcy court to dismiss this case by argument that LTL is not a factor in financial hardship.

“The filing is an incredibly legal and ineffective attempt by a small number of law firms to stop claimants from deciding on the resolution plan–a plan the vast majority of claimants are in favor of,” J&J’s litigation chief Erik Haas, said in a statement. Talc breast cancer. “The law firms involved in the filing are pursuing financial interests which clash with, contradict and oppose the interests they represent. We will be submitting an appeal before the court of appeals.”

Talc breast cancer. Clay Thompson, a lawyer for MRHFM who boasts more than patients with mesothelioma who have sued J&J and J&J, has said that J&J’s second bankruptcy attempt failed.

“J&J publishes press release describing how fantastic the plan is but simultaneously requesting that details of the plan, such as what the individual sick individuals would be treated to,” Thompson said in a statement. “What does the company have to conceal?”

Kaplan has instructed the sides to come up with another restructuring plan, with the supervision from two mediators.

The court in February of 2022 Kaplan affirmed the ability of J&J’s recourse to Chapter 11 to hasten a settlement that will free J&J from the hundreds of thousands of claims over its talcum products.

However, in January of this year an appeals court of the federal government overturned the decision, ruling that the company could not be considered to be in “financial difficulty.”

In the event that J&J’s request to appeal to the U.S. Supreme Court was turned down the same month, J&J was granted a second petition for bankruptcy two hours later. In response, Kaplan froze the lawsuits for 60 days in order to determine whether or not to approve the second bankruptcy.

J&J’s unstoppable profit engine sputters after $6.9B cost of litigation involving talc.

With two Chapter 11 attempts, J&J has purchased 19 months of which the cases were on hold. Talc breast cancer. J&J wants the claimants to take a vote to accept their settlement. J&J needs 75% approval for the deal to pass.

In addition to the group of talc lawyers who criticised the company’s bankruptcy in the U.S. Trustee, the U.S. Trustee is an arm of the U.S. Department of Justice is also submitting an application to dismiss the second bankruptcy case of LTL.

In a statement this week, U.S. trustee Andrew R. Vara wrote that the bankruptcy are “open to honest, but naive debtors.” Those doors “are not accessible to those that lack a legitimate bankruptcy goal or who seek to abuse the bankruptcy process to delay or hinder their creditors.” Vara continued.

For its part, J&J maintains there is no conclusive evidence that its Talc products, which includes its iconic baby powder, cause cancer. J&J has taken the products from the market and will first launch them on North America in 2020–and the rest of the world this year.

J&J wants to avoid the costly business of going to court. It has prevailed in most of the cases that were decided in court, however some losses have been punitive.
A well-known trial in Missouri ended in a $4.7 billion judgment against the drug manufacturer and was later lowered to $2.1 billion following appeals.

Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: report
In all, J&J has lost nine trial involving talc that are on appeal or have been decided. Of the 41 trials, 32 ended with an outcome for J&J or a mistrial, or verdict of a plaintiff annulled in appeal. Talc breast cancer. The company also has announced plans to settle more than 1000 cases for the sum of $100 million. Bloomberg published at the time.

Talcum Baby Powder Ovarian Cancer Lawsuit – Talc Breast Cancer

Our lawyers handle baby powder lawsuits across every state. The talcum powder lawsuits for Johnson & Johnson have been ongoing for many years. Talc breast cancer. The lawsuits assert that long-term use of talcum powder (or “talc”), the active ingredient in many products, including Baby Powder as well as Shower to Shower and Shower to Shower, could cause cancer of the ovary in certain women.

This article provides a J&J Talc Power Update and explains how the forthcoming bankruptcy ruling will impact the final settlement amounts in these ovarian cancer lawsuits.

Have you reached the deadline by which you to make a claim for talcum powder? Many who assume the statute of limitations has run out to sue Johnson & Johnson are wrong. Contact us now at 800-553-8082 or get a no-cost, quick review of your case online.

Johnson and Johnson Talcum Powder Lawsuit Update 2023 – Talc Breast Cancer

June 2 2023 Update: During the trial for asbestos-containing talc that took place in California yesterday, a couple of technical issues interrupted the opening statement by the defense lawyers. Talc breast cancer. Jurors who were watching at home via Zoom however, heard Johnson & Johnson’s lawyer voice his doubt about the 70s research claiming asbestos was present in their product, but the session abruptly ended.

In the meantime, the plaintiff was able to present the first of their witnesses, Arthur Langer. Langer said that the presence of additional minerals along with the talc’s mineral content is inevitable. He said that his team advised J&J in the year 1971 about the presence of asbestos chrysotile in the company’s talc, albeit in lower than 0.1 percent. He also found more asbestos in the year 1976.

June 1, 2023 Update: Talc breast cancer. The first trial since J&J has decided to separate its talc division and declare bankruptcy marks an important moment within the ongoing litigation saga. The trial began on Tuesday in the harrowing trial of a young plaintiff, diagnosed with a rare and aggressive form of mesothelioma last year. an illness that lawyers on both sides of the argument agree is a tragic loss.

Opening statements laid bare stark differences in each side’s story. The attorney representing the plaintiff aimed his ire on Johnson & Johnson, alleging the use of misleading techniques in its research practices and throughout the litigation process. The attorney claims that, according to, the company attempted to manipulate the definition of asbestos, in spite of internal documents dating from 1998 and 1994 that show fibers discovered in the tissue of the plaintiff are included.

Johnson & Johnson’s precarious $8.9 billion settlement proposal hangs in the balance with the course of this trial. Despite the unique nature of this mesothelioma case and its distinct issues compared to other talcum powder lawsuits, a verdict favoring the plaintiff could be the company with a major setback in its expectations of widespread acceptance of their proposed settlement among plaintiffs.

May 31, 2023: Update from Johnson & Johnson’s bankrupt talc unit is defending the second Chapter 11 filing in the face of challenges from injured talc claimants. In an appeal to the New Jersey bankruptcy court, the company argued that the case was vastly different from the first filing. The subsidiary emphasized the record-breaking commitment to $8.9 billion by J&J as the largest ever settlement in any bankruptcy case that involves mass tort. Talc breast cancer. The issue is not discussed: whether the magnitude of the settlement implies that it is a fair settlement. J&J also claimed support from various plaintiffs’ law firms representing over sixty thousand claimants. This is hard to verify but likely incorrect.

May 24 2023 Update: As of Johnson & Johnson’s bankruptcy in 2021 filing, the very first trial regarding its cosmetic talc products allegedly that contain asbestos is scheduled to commence jury selection on Monday, California at Alameda County Superior Court, the most favored place for plaintiffs. The plaintiff claims his mesothelioma resulted from asbestos exposure through J&J’s products and that the company is denying. The trial also involves six retailers who are accused of selling talc-based products.

May 22nd, 2023 Update: Lawyers involved in the second J&J Talc bankruptcy are in a dispute over who should be chosen to fill the role of a future claims representative, a role that is critically critical to resolving claims involving talc. Talc breast cancer. Randi Ellis, a lawyer who frequently appears in MDLs across the country, was appointed as the claims representative in the previous bankruptcy. J&J’s defense team wants Ellis to be appointed to this position and again, but attorneys for the talc plaintiffs are objecting to the claim that Ellis has conflicts of interest that should prevent her from assuming that position for the second time. The conflict stems from the fact that Ellis was believed to have been involved in the creation of the hotly disputable second bankruptcy, which raises doubts about her capacity to be neutral. In reality, this bankruptcy could be dismissed regardless.

May 17, 2023 Update The pretend company that J&J made up for the talc litigation bankruptcy informed an New Jersey bankruptcy court that they have allocated $400 million to settle claims brought by states accusing the company of deceitful advertising regarding its talc products. Talc breast cancer. So that makes it an $8.5 billion settlement for cancer patients. It is hard to imagine an eventuality where J&J can push these baby powder settlements through in these figures. While J&J’s proposed $8.5 billion offer seems like a lot initially, it may not look very appealing when you look at the numbers. The settlement plan based on our rough calculations – would not pay victims much more than an average settlement $100,000 per case. That is not enough.

May 15th, 2023 Update: J&J could be facing lawsuit by an advocacy group that represents cancer patients. Talc breast cancer. The group claims J&J deliberately withdrew an $61.5 billion funding agreement that it had with its company subsidiary LTL Management LLC, to simulate financial distress and verify the unit’s Chapter 11 bankruptcy filing. The group claims that this move is a fraud transfer of the rights of victims’ compensation. They are planning to study J&J’s actions in the wake of the dismissal of LTL’s first bankruptcy suit.

May 10 2023 Update: Next week, this week the U.S. Bankruptcy Court in New Jersey will hear oral arguments in a motion dismiss the second bankruptcy filing by J&J LTL Management, J&J’s subsidiary. LTL Management. However, in the meantime, the bankruptcy has issued an Order which requires both sides to take part in a settlement mediation in the hope that an international settlement agreement can be come to fruition.

May 5th, 2023: Update on Talc manufacturer Whittaker, Clark & Daniels filed for Chapter 11 bankruptcy due to numerous lawsuits alleging that its Talc products caused cancer from asbestos exposure. Talc breast cancer. Over 2,700 individuals have sued the company and it has been spending $1 million a month for legal defense. The company’s latest $29 million verdict at the Supreme Court of South Carolina forced it to apply for bankruptcy protection and argue for an equitable distribution of assets to talc claimants, rather than being confiscated through the receiver. Other suppliers of talc have declared bankruptcy because of the litigation.

May 4 2023, Update U.S. The bankruptcy Judge Michael Kaplan has directed Johnson & Johnson to resume talks on settlement with lawyers who rejected the company’s $8.9 billion deal. The court in Trenton, New Jersey yesterday the parties appeared before a judge to discuss next steps to take in the second bankruptcy case. Judge Kaplan was pushing for more settlement discussions.

This is the solution to resolve the claims of J&J. A baby powder settlement can be completed. Talc breast cancer. However, it’ll require more money – more billions of dollars – of Johnson & Johnson.

Lawyers have a split opinion on whether to take the proposal or not and not every client sees the situation the same way their lawyer sees it. The second bankruptcy case is bound to fail with Judge Kaplan has set a date for a hearing in June to determine if she will remove the bankruptcy after the second.

May 3 2023 Update A group of cancer patients suing Johnson & Johnson (J&J) requested to have J&J’s Third Circuit halt the bankruptcy filed by J&J subsidiary LTL Management, claiming it is an attempt to derail the litigation surrounding talc-based products. The group representing the claimants has filed a motion this week, asking the Third Circuit to consider their appeal and return the case to a lower court, with instructions to dismiss the bankruptcy. Talc breast cancer. They also asked that the halted tort litigation against J&J allow the litigation to continue.
LTL requested Chapter 11 protection once again after its bankruptcy filing was rejected in the Third Circuit earlier this year, offering the possibility of an $8.9 billion settlement. The committee believes that the recent decision allowing LTL’s third Chapter 11 to continue, while also halting trials against J&J is a reason for the immediate Third Circuit review. The US Trustee also asked that an New Jersey bankruptcy court dismiss the LTL bankruptcy case. J&J’s global vice president of litigation, Erik Haas, was quoted by Bloomberg saying that J&J plans to file a reply in the appeals court calling the request a “desperate and legally inadequate move” by a select group of law firms who have different financial interests.
May 1st 2023 Update: A common question that people ask is how plaintiffs and their lawyers be able to turn off $8.9 billion. That’s of course quite a sum. However, there are lots of victims. Talc breast cancer. And these are really good arguments for plaintiffs. We were reminded recently by two talc-related trials that led to huge verdicts for plaintiffs. In February mesothelioma cases, a talcum powder trial in Oregon was settled with the verdict worth $18.1 million. In the same month, a different mesothelioma trial involving talc was held for trials on the other side of South Carolina and resulted in an award of $29 million to the plaintiff. The defendant in both cases was Whittaker, Clark & Daniels Inc. one of the leading producers of talc in the U.S.
April 30th 2023 Update: When J&J first tried to bring the lawsuit over talcum powder into bankruptcy, it did so with the option of putting aside $2 billion to settle the case. It was a ridiculously small amount. None of the talc plaintiffs agreed with the offer. However, this time, J&J has increased the offer to $8.9 If the talc plaintiffs agree to a bankruptcy settlement and they also have the backing of a significant portion of the talc plaintiffs and their lawyers. Talc breast cancer. However, 75% of plaintiffs of talc are needed for approval of the bankruptcy plan is a difficult road because of the number of lawyers who have large stocks of baby powder-related lawsuits, opposed in favor of the deal.

What can be done to end the impasse? More billions.
April 25, 2023 update: Talc cancer claimants have requested a judge to reject their Chapter 11 case filed by LTL Management LLC, a absurdly-made-up Johnson & Johnson subsidiary, saying the company is not financially troubled. LTL applied for Chapter 11 to settle tens of thousands of claims that J&J’s baby-powders caused cancer. Talc breast cancer. LTL was denied Chapter 11 in January. 3rd Circuit dismissed its first Chapter 11 case in January in a ruling that said LTL was not eligible for bankruptcy relief as it failed to show financial trouble.

The claimants assert that the second Chapter 11 case is an misuse of the bankruptcy system and that the case is being handled in bad faith. J&J states that the bankruptcy settlement receives “significant backing” from the firms that represent around 60,000 plaintiffs. It is fair to say that lawyers representing plaintiffs and victims are divided over their disagreement over the $8.9 billion amount of settlement offered.

April 21st, 2023 Update A bankruptcy judge decided that Johnson & Johnson must face new lawsuits alleging that the company offered a baby powder with a contaminant that caused cancer. Although trials for talc lawsuits are paused for a minimum period of 60 days however, new lawsuits may be filed and lawyers are able to begin preparing their cases. Talc breast cancer. The judge expressed his doubts about J&J’s absurd attempt to revive its strategy with another bankruptcy case.

April 13th, 2023 update: the most important news is the $8.9 billion over the next 25 years settlement offer. Lawyers representing cancer patients in the MDL class action have vowed to fight the settlement with Talc claimants. Why? They feel it’s too little money for the more than 70,000 cancer victims. Talc breast cancer. These lawyers argue that J&J could negotiate a greater settlement or litigate individual claims if the most recent bankruptcy is declared unconstitutional.

But there’s a separate lawyer group that isn’t part of the leadership of the class action. These lawyers have collectively amassed many thousands of cases. The group is seeking to settle for what is believed to be lower than what the victims should be paid. Their argument appears to be twofold. First, they argue the settlement – about an average of $100,000 per plaintiff – is fair.

This is an argument that is difficult to argue. However, their second argument has more substance: the victims will be no longer patient and demand the money immediately.

April 12 2023 Update: People are looking for ways J&J can go through bankruptcy once more. The answer is complex and confusing. Let’s try to clarify it clearly.
Johnson & Johnson asserts that bankruptcy is the only option to settle both present and future talc lawsuits conclusively. In other words, it believes it can pay less when there is a bankruptcy element that creates pressure to negotiate a settlement. Talc breast cancer. Driving past 400 years of American time, the business believes that bankruptcy is beneficial to all parties as it distributes settlement payments more equitably and effectively than trial courts, which are where litigants get significant settlements while others get nothing.

The main thrust of this 3rd Circuit decision was this is not a matter of a profitable company making an entity to assume the legal burden and declare bankruptcy – something Congress considered when it was drafting the Bankruptcy Code. It also clarified it was not financially crisis because J&J offered unlimited financing.
Then J&J took advantage of the unlimited funding aspect of the agreement and didn’t promise to fund unlimited lawsuits. J&J claims that its updated financing arrangements with its subsidiary address appeals court’s concerns while still offering funds to pay claims. It’s as if giving victims lesser money could solve the overall issue.

Lawyers representing cancer patients who do not agree with the agreement counter this by arguing that the plaintiff is a defense against legal nonsense by pointing out legal nonsense: J&J fraudulently transferred $50 billion in assets away from LTL Management to circumvent the appeals court’s previous ruling. Hyperbole did not go unnoticed by the victims’ lawyers, who call it the largest “fraudulent transaction of assets in United States history.”

Despite the legal jargon, J&J does not really believe this bankruptcy will be able to last. But it’s a way of pushing this $8.9 billion settlement and keep pressure on plaintiffs.

April 10 2023 Update Bloomberg provides an insightful article about a new law within New Jersey that is shedding new light on litigation funding in the baby powder plaintiffs in the class action. Funders for litigation Virage Capital Management and TRGP Capital invested in hundreds of claims that were brought against Johnson & Johnson (J&J) concerning talc products in exchange for a portion of any settlements. J&J is now willing to pay $8.9 billion to settle all lawsuits.

The funders’ involvement is publicly available because of a New Jersey court rule requiring the disclosure of certain information about outside funding backers. This rule is intended to tackle the growing demands for regulation of litigation funders. J&J has to deal with more than 60,000 lawsuits when you add up federal and state infant powder litigation. Third-party funding in mass tort claims has both pros and cons. There is no doubt that we are witnessing how third-party funding can level the playing field between individual and large corporations in court.

April 4, 2023 Update: It is interesting to watch the worm turn in this litigation. J&J has taken another blow this week when they were denied by the Third Circuit denied J&J’s request to keep the automatic stay in place while J&J appeals an order granting bankruptcy in the U.S. Supreme Court. This automatic stay frozen thousands of talcum cases and stopped new lawsuits from being filed ever since J&J began the controversial plan to spin the talc debts off into a bankrupt company over one year back. Talc breast cancer. After the 3rd Circuit ruled that this bankruptcy was not valid only a few months back, the stay was removed. J&J had hoped to have it stayed in place until hearing the SCOTUS appeal. The answer was no.
April 1, 2023 Update: Johnson & Johnson announced it will appeal its 3rd Circuit bankruptcy loss to the U.S. Supreme Court last week. The chance is that the Supreme Court is willing even to hear the appeal? Low.
March 16th 2023 Update: with the bankruptcy stay now fully lifted, the first new cases were filed and incorporated into the talcum powder class action MDL within a year. Seven new talc cases were joined to the MDL in the past month and brought the total number of cases pending to 37,522.

February 25, 2023 Update This morning, a Congressmen from Tennessee is now calling for The U.S. Government Accountability Office (GAO) start an investigation into the amount J&J talc products have cost the government over the decades.
A recent email addressed to the GAO, Rep. Steven Cohen (D-Ten.) has accused J&J of ignoring the dangers of its talc products over long while tax dollars used to treat those who were injured through exposure to the products. This lawsuit comes a few weeks after J&J’s loss to the 3rd Circuit Court of Appeals.

Talc breast cancer. J&J should begin to make reasonable settlement proposals to victims to the process of putting all this behind it. It’s a mark on one of the world’s greatest companies.

February 14 , 2023 Update: At a hearing today at the hearing in New Jersey, U.S. Bankruptcy Judge Michael Kaplan announced his intention to follow the ruling of 3rd U.S. Circuit Court of Appeals ruling to dismiss the bankruptcy case.